Enovis (ENOV) Return on Capital Employed (2011 - 2026)
Enovis (ENOV) posted quarterly Return on Capital Employed of 33.21% for Q2 2026, down 1498.0% year-over-year from 2.38% in Q2 2025, and down 4.44% quarter-over-quarter from 31.8% in Q4 2025.
Enovis (ENOV) Return on Capital Employed (2011 - 2026) Analysis & Trends
Enovis (ENOV) has reported Return on Capital Employed for 16 consecutive years, with 33.21% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed fell 1498.0% year-over-year to 33.21%; the TTM figure through Apr 2026 stood at 33.21% (down 1498.0% YoY), while the FY2025 annual figure was 30.56%, down 1157.0% from the prior year.
- Return on Capital Employed declined to 33.21% in Q2 2026 per ENOV's latest filing, from 31.8% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1.61% in Q4 2023 and bottomed at 33.21% in Q2 2026.
- Historically, Return on Capital Employed has averaged 10.02% across 5 years, with a median of 2.17% in 2023.
- Annual changes were most pronounced in 2023 — Return on Capital Employed soared 41 bps — and 2025, when it sank 2864 bps.
- Enovis' Return on Capital Employed stood at 1.88% in 2022, then gained by 14 bps to 1.61% in 2023, then tumbled by 947 bps to 16.84% in 2024, then slumped by 89 bps to 31.8% in 2025, then retreated by 4 bps to 33.21% in 2026.
- Business Quant data shows ENOV's Return on Capital Employed at 33.21% in Q2 2026, 31.8% in Q4 2025, and 30.99% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Enovis | 1.50 Bn | 1.48 Bn | 359.25 Mn | -32.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -32.53% |
| Apr 3, 2026 | -33.21% |
| Dec 31, 2025 | -31.80% |
| Oct 3, 2025 | -30.99% |
| Jul 4, 2025 | -17.35% |
| Apr 4, 2025 | -18.23% |
| Dec 31, 2024 | -16.84% |
| Sep 27, 2024 | -2.35% |
| Jun 28, 2024 | -2.13% |
| Mar 29, 2024 | -1.70% |
| Dec 31, 2023 | -1.61% |
| Sep 29, 2023 | -2.17% |
| Jun 30, 2023 | -2.13% |
| Mar 31, 2023 | -1.66% |
| Dec 31, 2022 | -1.88% |
| Sep 30, 2022 | -1.69% |
| Jul 1, 2022 | -2.54% |
| Apr 1, 2022 | -2.03% |
| Dec 31, 2021 | 0.23% |
| Oct 1, 2021 | -1.99% |